Southwest to Pour $...
Health Care: Drugs
Infinity Pharmaceuticals Inc. (INFI: NASDAQ)
$12.30 0.37 | 3.10%
05/24/12 - 12:45 PM ET
120.62K / 214.10K
Vol / Avg. Vol:11.93 / 11.93
Open / Prev. Close:11.81 - 12.39
Today's Range:5.50 - 13.75
52 Wk Range:40.27%
Performance YTD:TheStreet Rating:
Portfolios with INFI
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Under-$10 Moving Hig...
- Contributor8 Health Care Stocks With R...
- UserASCO 2010
- UserPART 7 JPMorgan 28th Annual...
- UserASCO 2009 Nymph's Watch List.
- UserPART 6 JPMorgan 27th Annual...
- UserPART 7 JPMorgan 26th Annual...
- UserBENITRANS EA
- Userneelkevin Portfolio 1
Latest INFI Headlines from TheStreet
- Threshold Drug Delays Pancreatic Cancer 02.21.12 | 01:02 pm
- Infinity Stock Gaps Down On Today's Open (INFI) 01.27.12 | 08:01 am
- 8 Health Care Stocks With Recent Gains 06.29.11 | 02:06 pm
- Infinity To Present New Preclinical Data On IPI-926, A Novel Smoothened Antagonist Targeting The Hedgehog Pathway, At Upcoming AACR Meeting 03.23.11 | 08:03 am
- Infinity Provides Company Update And Reports Fourth Quarter And Full-Year 2010 Financial Results 03.15.11 | 04:03 pm
- Infinity Announces The Date Of Its Fourth Quarter 2010 Financial Results Conference Call And Webcast 03.08.11 | 08:03 am
- Infinity Initiates Phase 2 Trial Of IPI-926 In Patients With Chondrosarcoma 03.03.11 | 08:03 am
- Infinity Pharmaceuticals To Present At Two Upcoming Conferences 02.28.11 | 08:02 am
- Infinity Initiates Phase 2 Portion Of Trial Of IPI-926 In Pancreatic Cancer 02.22.11 | 08:02 am
- Infinity Provides 2011 Goals And Guidance 01.07.11 | 08:01 am
Press Releases for INFI
- Infinity Added To NASDAQ Biotechnology Index - Business Wire 05.15.12 | 08:05 am
- Infinity Announces The Date Of Its First Quarter 2012 Financial Results Conference Call And Webcast - Business Wire 05.01.12 | 08:05 am
- Infinity Pharmaceuticals To Present At Two Upcoming Conferences - Business Wire 04.13.12 | 08:04 am
- Infinity Reports New Preclinical Data For Saridegib At AACR Supporting Development In Residual Disease Settings - Business Wire 04.01.12 | 05:04 pm
- Infinity Pharmaceuticals To Present At The 11th Annual Needham Healthcare Conference - Business Wire 03.28.12 | 04:03 pm
- Infinity Provides Company Outlook And Reports Full-Year And Fourth Quarter 2011 Financial Results - Business Wire 03.13.12 | 04:03 pm
- Infinity Appoints Two Experienced Industry Leaders To Its Board Of Directors - Business Wire 03.12.12 | 08:03 am
- Infinity Announces The Date Of Its Fourth Quarter 2011 Financial Results Conference Call And Webcast - Business Wire 02.27.12 | 08:02 am
- Infinity Pharmaceuticals To Present At Cowen Healthcare Conference - Business Wire 02.21.12 | 08:02 am
- Infinity Pharmaceuticals Announces Its Participation At Three Investor Conferences - Business Wire 02.06.12 | 08:02 am
Partner Headlines for INFI
- Noteworthy Institutional 5% Ownership Filings On Friday - Seeking Alpha 04.02.12 | 08:04 am
- AACR Annual Oncology Meeting: A Look Into Various Abstracts - Seeking Alpha 03.27.12 | 09:03 am
- Earnings Expectations for the Week of March 12 (URBN, ROST) - Benzinga 03.11.12 | 11:03 am
- Company News for January 30, 2012 - Corporate Summary - Zacks 01.30.12 | 10:01 am
- Baker's Dozen Trying To Beat The Odds In Pancreatic Cancer - Seeking Alpha 10.25.11 | 08:10 am
- Company News for May 10, 2011 - Corporate Summary - Zacks 05.10.11 | 10:05 am
- Infinity Pharmaceuticals: A Promising, Underappreciated Cancer Drug Maker - SeekingAlpha.com 04.14.10 | 04:04 am
